Robert Shepler Overview
- Company
- Akoya Bioscience...
- Primary Position
-
Chairman & Board...
- Primary Industry
-
Healthcare
- Active Board Seats
-
1
- Med. Deal Size
-
- Med. Valuation
-
Robert Shepler General Information
Biography
Mr. Robert Shepler serves as the Board Member at Akoya Biosciences. He co-founded and served as Partner Emeritus at Telegraph Hill Partners. He and Matt Mackowski partnered together in 1991 to form THP's predecessor focused on investing in private healthcare companies. He served as Board Member at RareCyte. During his career, he has served on numerous company boards and completed over 200 M&A and financing transactions. He has represented THP on the boards of AcroMetrix (acquired by Life Technologies), Agena Bioscience (acquired by Mesa Laboratories), Akoya Biosciences (NASDAQ:AKYA), Applied Precision (acquired by GE), Aurora Discovery (acquired by NEXUS Biosystems), Dynex, Estech (acquired by AtriCure), Kinetikos Medical (acquired by Integra), LDR Spine (IPO: LDRH; acquired by Zimmer Biomet), Sage Labs (acquired by Horizon Discovery) and Vidacare (acquired by Teleflex). He was also an observer on the board of Precision NanoSystems (acquired by Danaher). Prior to joining with Mr. Mackowski, he worked with Merrill Lynch & Co. as an officer in their San Francisco corporate finance office, where he managed financings and acquisitions for Fortune 500 and selected high growth companies. He received a BA from Duke University and an MBA from New York University.
Contact Information
Address
- 1080 O'Brien Drive
- Suite A
- Menlo Park, CA 94025
- United States
Robert Shepler Board Seats (1)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Akoya Biosciences | Other Healthcare Technology Systems | Publicly Held | Formerly VC-backed | Marlborough, MA |
Robert Shepler Lead Partner on Deals (13)
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
RareCyte | 05-Jul-2017 | Later Stage VC (Series C) | Completed | Diagnostic Equipment | Seattle, WA | |
RareCyte | 21-Aug-2012 | Completed | Diagnostic Equipment | Seattle, WA | ||
Estech | 07-Dec-2010 | Completed | Medical Supplies | San Ramon, CA | ||
Estech | 02-Jun-2009 | Completed | Medical Supplies | San Ramon, CA | ||
Estech | 12-Aug-2008 | Completed | Medical Supplies | San Ramon, CA | ||
Applied Precision (Life Sciences Business Unit) | 07-May-2008 | Completed | Discovery Tools (Healthcare) | Issaquah, WA | ||
VidaCare | 06-Sep-2007 | Completed | Surgical Devices | San Antonio, TX | ||
VidaCare | 29-Dec-2005 | Completed | Surgical Devices | San Antonio, TX | ||
Estech | 25-Aug-2005 | Later Stage VC | Completed | Medical Supplies | San Ramon, CA | |
VidaCare | 12-Dec-2004 | Early Stage VC (Series B) | Completed | Surgical Devices | San Antonio, TX |
Robert Shepler Network (65)
Board Members (37)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Trit Garg MD | RareCyte | HealthQuest Capital | Seattle, WA | |
Brian Daniels MD | RareCyte | 5AM Ventures | Seattle, WA | |
VidaCare | Self | San Antonio, TX | ||
RareCyte | HealthQuest Capital | Seattle, WA | ||
VidaCare | Self | San Antonio, TX |
Portfolio Executives (19)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Jim Cooper | RareCyte | Vice President, Finance | 05-Jul-2017 | Seattle, WA |
Frank Witney Ph.D | RareCyte | Advisor | 05-Jul-2017 | Seattle, WA |
RareCyte | Senior Vice President, Clinical Research | 05-Jul-2017 | Seattle, WA | |
RareCyte | Chief Business Officer | 05-Jul-2017 | Seattle, WA | |
RareCyte | Chief Financial Officer | 05-Jul-2017 | Seattle, WA |
Fund Team Members (9)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Paul Grossman Ph.D | Telegraph Hill Partners | Telegraph Hill Partners III | San Francisco, CA |
Deval Lashkari Ph.D | Telegraph Hill Partners | Telegraph Hill Partners III | San Francisco, CA |
Telegraph Hill Partners | San Francisco, CA | ||
Telegraph Hill Partners | San Francisco, CA | ||
Telegraph Hill Partners | San Francisco, CA |
Robert Shepler Affiliated Funds (3)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
Telegraph Hill Partners | Telegraph Hill Partners | Venture - General | Closed | 2002 | ||||
Telegraph Hill Partners II | Telegraph Hill Partners | Venture - General | Closed | 2006 | ||||
Telegraph Hill Partners III | Telegraph Hill Partners | Venture - General | Closed | 2013 |
Robert Shepler FAQs
-
Who is Robert Shepler?
Mr. Robert Shepler serves as the Board Member at Akoya Biosciences.
-
How much does Robert Shepler typically invest?
Robert Shepler's median deal size is
. -
What is Robert Shepler’s main position?
Robert Shepler’s primary position is Chairman & Board Member.
-
How many active board seats does Robert Shepler hold?
Robert Shepler holds a board seat in Akoya Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »